Search

everythinglearnresearchcommunity

for

Search:↓

Gray hair is caused by reduced melanin production or transfer issues, linked to aging and possibly health conditions, with treatments focusing on color camouflage.

Maintaining sexual health after menopause is possible with patient approaches, hormone supplements, and therapy, despite needing more research.

Minoxidil promotes hair growth but exact mechanism is unknown.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

Fluconazole might be a new treatment for a type of diabetes that affects water balance in the body.

The document concludes that early diagnosis and treatment are key for pediatric hair loss disorders, and addressing the emotional effects on children is important.

Some natural remedies may help with hair regrowth, but more research is needed to confirm their effectiveness and safety.

Personalized thiopurine dosing based on NUDT15 genotyping can improve long-term outcomes for ulcerative colitis and Crohn's disease patients.

Human hair is a significant sample for various tests in clinical, nutritional, archaeological, and forensic studies.

Patients need better information about the risks of long-term steroid use.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Sex hormones affect reproduction, sexual development, and oral health, and it's important for dental practitioners to understand their effects and interactions.

Methotrexate is effective for treating rheumatoid arthritis but requires regular monitoring.

Some botanical products may help increase hair growth in people with alopecia, but more research is needed.

There is no significant link between insulin resistance and certain hair disorders like idiopathic hirsutism and androgenic alopecia.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

The document summarizes recent dermatological treatments and advances in areas like pediatric care, wound healing, skin closure, light-based therapies, pigment disorders, hair loss, immunotherapy, infection management, melanoma, drug reactions, and facial rejuvenation.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Finasteride effectively treats BPH, but needs more trials to understand potential.

Hair color production in mice is closely linked to the hair growth phase and may also influence hair growth itself.

Visible light can damage skin and most sunscreens don't block it well; more research is needed on its effects and protection methods.

Flutamide rarely causes liver toxicity in prostate cancer patients.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

Hair color production is closely linked to the active growth phase of hair in mice and may also influence hair growth itself.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

The Protein-Sparing Modified Fast is effective for rapid weight loss and maintaining it, but requires medical supervision and can have side effects.

Minoxidil promotes hair growth but stops working when discontinued.